New drugs to prevent dry eyes can be developed using very-long chain lipids found in the most superficial layer of the tear film, finds a new study.

About 80 percent of dry eye disease cases are caused by abnormalities in this lipid layer. Although drugs targeting the water and mucin layers are available, no drug has been manufactured to target the lipid layer.
Tear film lipids are secreted by the meibomian gland and are called meibum, a molecular chain composed of cholesteryl esters and wax esters. The meibum carbon chain is generally very long, having from 20 to 34 constituent carbons. But much about meibum remains unclear, such as the significance of its long chains and its role in preventing dry eye disease.
The research team led by Akio Kihara of Hokkaido University created mice whose Elovl1 gene, which encodes an enzyme that elongates fatty acid chains, was deleted from everywhere but the skin, knowing that knocking out the gene in the skin is lethal. The team observed that when young, the knockout mice blinked frequently and exhibited signs of dry eye disease, such as increased water evaporation from the tear film. After five months, many of the mice developed cloudy corneas. The corneal abnormalities are believed to have been caused by prolonged dry eyes, which inhibited self-repair of the damaged cornea.
The scientists also found that the knockout mice had less very long-chain meibum (25 carbons), but more short-chain meibum.
These results indicate Elovl1 is closely linked to the synthesis of very long-chain meibum, which appear to be essential to preventing dry eye disease. "Our results could help develop new drugs to treat and prevent the dry eye disease, such as agents that promote the secretion of very long-chain meibum or eye drops containing these lipids," says Kihara.
Advertisement
Advertisement